Sotatercept approved by FDA
March 27, 2024
Merck, also known as MSD outside of the United States and Canada, has announced the FDA approval of Winrevair™ (sotatercept), a groundbreaking biologic for the
Merck, also known as MSD outside of the United States and Canada, has announced the FDA approval of Winrevair™ (sotatercept), a groundbreaking biologic for the
As we turn the page on another remarkable year, it’s with immense pride and gratitude that I reflect on the journey that was 2023. This